Print Options

Font size:

← Back to notecard set|Easy Notecards home page

To print: Ctrl+PPrint as notecards

TEST #1: PE AND SHOCK

1.

WAYS TO PREVENT VTE

  • SQ HEPARIN OR LMWH
  • LIFESTYLE CHANGES
  • GRADUATED COMPRESSION STOCKINGS/SCD PUMPS TO PREVENT DVT
  • LIFESTYLE CHANGES: HEALTHY WEIGHT, EXERCISE, HYDRATION, NO SMOKING, AVOID SITTING W/ LEGS CROSSED FOR LONG PERIODS OF TIME, WHEN TRAVELING, CHANGE POSITION FREQUENTLY
  • MEDICATION COMPLIANCE
  • EARLY AMBULATION AND LEG EXERCISES
  • INT PNEUMATIC COMPRESSION DEVICES
  • DON'T MASSAGE LEG W/ DVT
2.

IF A PATIENT CURRENTLY HAS A DVT, SHOULD YOU APPLY ANTI-EMBOLIC STOCKINGS/SCD PUMPS TO AFFECT LEG

NO!

3.

WHAT CAN UNSTABLE PE LEAD TO?

THE SUDDEN INCREASED IN PULMONARY RESISTANCE INCREASES THE WORK OF THE RIGHT VENTRICLE, WHICH CAUSES R SIDED HEART FAILURE W/ CARDIOGENIC SHOCK

4.

NURSE INTERVENTIONS POST SURGICAL EMBOLECTOMY

  • MEASURE I'S AND O'S
  • PULMONARY ARTERIAL PRESSURE
  • ASSESS INSERTION OF ARTERIAL CATH FOR HEMATOMA FORMATION AND INFECTION
  • ELEVATE FOOT OF BED
  • ENCOURAGE ISOMETRIC EXERCISES
  • SCDs
  • WALKING
5.

CAUSES LYSIS OF BLOOD CLOTS

THROMBOLYTICS

  • ALTEPLASE
  • RETEPLASE
6.

WHAT MEDICATIONS CAN YOU NOT TAKE WHILE TAKING ALTEPLASE

OTHER ANTICOAGULANTS

7.

WHAT LABS ARE CHECKED BEFORE ADMN OF THROMBOLYTICS?

  • aPTT
  • INR
  • CBC
  • INR
8.

NURSING ACTIONS WHILE ADMINISTERING THROMBOLYTICS

  • MONITOR FOR BLEEDING
  • BEDREST
  • AVOID INVASIVE PROCEDURES
  • APPLY MANUAL PRESSURE TO PUNCTURE SITE FOR 30 MINUTES
  • NO IM INJECTIONS/LAB STICKS
  • MONITOR VS AND NEURO CHECKS FREQUENTLY
9.

PATIENT SHOULD NOT BE RECEIVING ANTICOAGULANTS IF THEY HAVE THIS?

WHAT IS IT?

IVC FILTER - ALLOWS BLOOD TO FLOW UNOBSTRUCTED W/ LARGE EMBOLI FROM PELVIS OR LE ARE BLOCKED OR FRAGMENTS

10.

WHAT LAB DO YOU CHECK WITH PATIENTS TAKING HEPARIN AND ENOXAPARIN?

PLATELETS

11.

WHAT IS THE ANTIDOTE FOR HEPARIN/ENOXAPARIN?

PROTAMINE SULFATE

12.

CAN YOU ADMINISTER WARFARIN CONCURRENTLY W/ HEPARIN/ENOXAPARIN?

YES, UNTIL INR REACHES 2

13.

REVIEW SLIDES 24-26

REVIEW